News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 21, 2025

Understanding CGM Metrics

Author(s)Davida Kruger, MSN, APN-BC, BC-ADM , Jaime Murillo, MD, FACC, FASE , Ian Neeland, MD, FAHA, FACC

Experts discuss the relative value of different continuous glucose monitoring (CGM) metrics (glucose management indicator [GMI], time in range, glucose variability) in assessing glycemic control and how these outcomes vary across different patient populations.

Episodes in this series

1 KOL is featured in this series.

EP. 1 CGM: Redefining Type 2 Diabetes Management

EP. 2 Key Benefits of CGM Technology

EP. 2 Key Benefits of CGM Technology

EP. 3 CGM's Impact on Clinical Inertia

EP. 3 CGM's Impact on Clinical Inertia

EP. 4 CGM vs Traditional Monitoring

EP. 4 CGM vs Traditional Monitoring

EP. 5 Understanding CGM Metrics

EP. 5 Understanding CGM Metrics

EP. 6 Health Care System Integration

EP. 6 Health Care System Integration

EP. 7 CGM Coverage and Access

EP. 7 CGM Coverage and Access

EP. 8 Implementation Barriers

EP. 8 Implementation Barriers

EP. 9 Overcoming Access Challenges

EP. 9 Overcoming Access Challenges

EP. 10 Adoption Strategies

EP. 10 Adoption Strategies

EP. 11 The Metro Nashville Public Schools Initiative

EP. 11 The Metro Nashville Public Schools Initiative

EP. 12 Health Care Quality Impact

EP. 12 Health Care Quality Impact

EP. 13 Population Outcomes and Return on Value With CGMs

EP. 13 Population Outcomes and Return on Value With CGMs

EP. 14 Long-Term Outcomes Assessment

EP. 14 Long-Term Outcomes Assessment

EP. 15 Closing Perspectives

EP. 15 Closing Perspectives

Video content above is prompted by the following:

Please discuss the relative value of different CGM metrics (GMI, Ttime in Rrange, glucose variability) in assessing glycemic control.

How do these outcomes vary across different patient populations?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Headshots of Brian Brooks and Sy Atezaz Saeed, MD, MS, FACPsych, on AJMC branded Contributor background

Student Mental Health, Success Tied to Future Health and Affordability

ByBrian Brooks,Sy Atezaz Saeed, MD, MS, FACPsych

August 22nd 2026

Child and father pediatric visit | Image credit: Talia Mdlungu/peopleimages.com - stock.adobe.com

Less Chemo, Similar Survival in Pediatric Orbital Rhabdomyosarcoma

ByLaura Joszt, MA

August 21st 2026

Ochsner Medical Center exterior | Image: Ochsner

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

August 21st 2026

Medical Professional Using Advanced Healthcare Technology Interface on a Smartphone for Patient Data Analysis in a Modern Clinical Setting | Image credit: FahVecStudio - stock.adobe.com

Mobile Integrated Health Valuable in Heart Failure, but Payment Lags

ByPearl Steinzor

August 21st 2026

Contributor: The Deadly Gap in the Charity Care System

ByJubril Oyeyemi, MD

August 21st 2026

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM